BIOPHARMACEUTICALS MARKET ANALYSIS

Biopharmaceuticals Market, By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Vaccines, Recombinant Enzymes, Cell and Gene Therapies, Synthetic Immunomodulators, and Other Product Types), By Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, and Other Diseases), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Jun 2023
Code : CMI5785
Pages :150
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Companies covered:

Amgen Inc., Abbvie Inc., GlaxoSmithKline PLC, Pfizer Inc., Novo Nordisk AS, Novartis AG, Johnson & Johnson, Eli Lilly and Company, Bristol-Myers Squibb Company, and F. Hoffmann-La Roche Ltd., among others.

Global Biopharmaceuticals Market: Key Companies Insights

The global biopharmaceuticals market is highly competitive. This is attributed to the rise in burden of chronic, infectious, and neurological diseases across the globe, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global biopharmaceuticals market are Amgen Inc., Abbvie Inc., GlaxoSmithKline PLC, Pfizer Inc., Novo Nordisk AS, Novartis AG, Johnson & Johnson, Eli Lilly and Company, Bristol-Myers Squibb Company, and F. Hoffmann-La Roche Ltd., among others.

BIOPHARMACEUTICALS MARKET ANALYSIS

Leading Companies

Biopharmaceuticals Market Report Snapshots

EXISTING CLIENTELE